TW250435B - - Google Patents

Info

Publication number
TW250435B
TW250435B TW079109396A TW79109396A TW250435B TW 250435 B TW250435 B TW 250435B TW 079109396 A TW079109396 A TW 079109396A TW 79109396 A TW79109396 A TW 79109396A TW 250435 B TW250435 B TW 250435B
Authority
TW
Taiwan
Prior art keywords
crohn
colitis
methods
budesonide
disease
Prior art date
Application number
TW079109396A
Other languages
English (en)
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW250435(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Application granted granted Critical
Publication of TW250435B publication Critical patent/TW250435B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
TW079109396A 1989-11-22 1990-11-07 TW250435B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
TW250435B true TW250435B (zh) 1995-07-01

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
TW079109396A TW250435B (zh) 1989-11-22 1990-11-07

Country Status (36)

Country Link
US (1) US6423340B1 (zh)
EP (1) EP0502092B1 (zh)
JP (1) JP3145111B2 (zh)
KR (1) KR0179042B1 (zh)
AT (1) ATE125445T1 (zh)
AU (1) AU643021B2 (zh)
CA (1) CA2071518C (zh)
DE (1) DE69021214T2 (zh)
DK (1) DK0502092T3 (zh)
EG (1) EG19642A (zh)
ES (1) ES2074698T3 (zh)
FI (2) FI104949B (zh)
GR (1) GR3017691T3 (zh)
HK (1) HK51897A (zh)
HR (1) HRP920632B1 (zh)
HU (2) HUT60630A (zh)
IE (1) IE74854B1 (zh)
IL (1) IL96415A (zh)
IS (1) IS1858B (zh)
LT (1) LT3696B (zh)
LV (1) LV10183B (zh)
MY (1) MY104535A (zh)
NO (1) NO304010B1 (zh)
NZ (1) NZ235807A (zh)
PL (1) PL166506B1 (zh)
PT (1) PT95946A (zh)
RU (1) RU2134104C1 (zh)
SA (1) SA90110123B1 (zh)
SE (1) SE8903914D0 (zh)
SG (1) SG54210A1 (zh)
SI (1) SI9012150A (zh)
TW (1) TW250435B (zh)
UA (1) UA37196C2 (zh)
WO (1) WO1991007172A1 (zh)
YU (1) YU48583B (zh)
ZA (1) ZA908777B (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
PL178307B1 (pl) * 1993-01-08 2000-04-28 Astra Ab Nowe pochodne steroidowe, sposób wytwarzania nowych pochodnych steroidowych i preparat farmaceutyczny do leczenia stanu zapalnego śluzówki jelita
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
CA2271560C (en) * 1996-11-15 2003-09-23 Mayo Foundation For Medical Education And Research Pharmaceutical dosage form for colonic delivery
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
WO2004052374A1 (en) 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2007056539A2 (en) * 2005-11-08 2007-05-18 Medarex, Inc. Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
EA022886B1 (ru) * 2008-10-03 2016-03-31 Др. Фальк Фарма Гмбх Способ поддержания ремиссии язвенного колита у пациентов
US8945615B2 (en) 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
MX2013009033A (es) * 2011-02-04 2013-09-06 Optimer Pharmaceuticals Inc Tratamiento de infecciones bacterianas.
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
NO2659881T3 (zh) 2012-04-30 2018-04-28
BR122020013726B1 (pt) 2013-10-29 2022-11-01 Tillotts Pharma Ag Formulação de droga de liberação retardada
RU2018111690A (ru) * 2015-09-11 2019-10-11 Сан Фармасьютикл Индастриз Лтд. Пероральная лекарственная форма будесонида
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
JP6954927B2 (ja) * 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
ES2874669T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (zh) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
DE69021214D1 (de) 1995-08-31
ES2074698T3 (es) 1995-09-16
FI104949B (fi) 2000-05-15
EG19642A (en) 1995-08-30
HU9201700D0 (en) 1992-08-28
IE904170A1 (en) 1991-05-22
ATE125445T1 (de) 1995-08-15
FI19991893A (fi) 1999-09-06
MY104535A (en) 1994-04-30
EP0502092B1 (en) 1995-07-26
GR3017691T3 (en) 1996-01-31
SI9012150A (sl) 1998-08-31
HRP920632A2 (en) 1995-04-30
IS1858B (is) 2003-03-27
SG54210A1 (en) 1998-11-16
JPH05501705A (ja) 1993-04-02
HUT60630A (en) 1992-10-28
SA90110123B1 (ar) 1999-06-06
AU7786491A (en) 1991-06-13
KR0179042B1 (ko) 1999-03-20
IL96415A0 (en) 1991-08-16
PL166506B1 (pl) 1995-05-31
US6423340B1 (en) 2002-07-23
YU48583B (sh) 1998-12-23
CA2071518C (en) 2002-11-12
SE8903914D0 (sv) 1989-11-22
CA2071518A1 (en) 1991-05-23
HK51897A (en) 1997-05-02
EP0502092A1 (en) 1992-09-09
LTIP1751A (en) 1995-07-25
DK0502092T3 (da) 1995-12-27
HRP920632B1 (en) 1999-10-31
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
NO922004L (no) 1992-05-21
IL96415A (en) 1995-11-27
LV10183A (lv) 1994-10-20
PL287844A1 (en) 1991-12-02
YU215090A (sr) 1996-01-09
WO1991007172A1 (en) 1991-05-30
IS3644A7 (is) 1991-05-23
NZ235807A (en) 1993-02-25
PT95946A (pt) 1991-09-13
FI922325A (fi) 1992-05-21
DE69021214T2 (de) 1996-01-04
KR920703025A (ko) 1992-12-17
HU216836B (hu) 1999-09-28
FI922325A0 (fi) 1992-05-21
UA37196C2 (uk) 2001-05-15
JP3145111B2 (ja) 2001-03-12
LT3696B (en) 1996-02-26
RU2134104C1 (ru) 1999-08-10
AU643021B2 (en) 1993-11-04
NO922004D0 (no) 1992-05-21
IE74854B1 (en) 1997-08-13
NO304010B1 (no) 1998-10-12

Similar Documents

Publication Publication Date Title
TW250435B (zh)
GEP20012448B (en) Tissue Plasminogen Activators (Improved Variants)
CS553490A3 (en) Transdermal therapeutic system
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
EP0151989A3 (en) Means for the treatment of cardiac diseases
BG106171A (en) Compositions and uses of et743 for treating cancer
GB9103764D0 (en) Compositions
EP0324802A4 (en) Method for the treatment of body tissues and the administration of drugs thereto
MD990258A (en) Method of treatment of the acute viral hepatitis B
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
GR3030600T3 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
ZA938959B (en) Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
NO920031D0 (no) Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi